Technology

AddToAny

Google+ Facebook Twitter Twitter

Diagnostics range launch

Horiba Medical UK has announced a significant development of its in vitro diagnostics product offering with the launch of its new Yumizen G range of instruments and reagents.

Marking a milestone in its new product development programme, the Yumizen G range extends Horiba Medical’s Haematology portfolio into the complementary field of Haemostasis – a new discipline for the company.

Horiba Medical has developed a reputation for expertise and excellence in blood cell analysis. This has been utilised to deliver the new and comprehensive range of Yumizen G systems and reagents for coagulation diagnostics.

Cleve Wright, Director of Horiba Medical UK, said: “By leveraging our extensive expertise in the Haematology field, we have significantly broadened our scope in blood disease analysis into a complementary discipline.”

horiba.com/uk/medical

Related Articles

news_in_numbers.png

August news in numbers

A breakdown of science news this month, in numbers.

British Journal of Biomedical Science, Issue 3 2019 – a synopsis

Editor Andrew Blann outlines the content of the summer issue of the journal.

August journal-based learning exercises

Please select your choice of correct answers and complete the exercises online at: www.ibms.org/cpd/jbl

My Lab: Red cell immunohaematology

Specialist Biomedical Scientist Helen Owens gives a guided tour of her reference laboratory at NHS Blood and Transplant, Newcastle.

Top